Are GERD Patients Really Getting Younger?
Yes. In a population-based analysis of the Explorys dataset, the proportion of patients with gastroesophageal reflux disease rose across nearly every age group over an 11-year period, and the largest rise was in people aged 30 to 39. The same pattern held whether the researchers looked at the “universal” dataset or at a single healthcare system in northern Ohio.
Dr. Kumar’s Take
This demographic shift in GERD is concerning but not surprising given modern lifestyle changes. The risk factors that drive reflux, high body mass index, limited physical activity, smoking, and the food and drink people consume, are lifestyle factors that now reach further down the age curve than they used to. That matters clinically, because a 35-year-old with reflux is looking at potentially decades of symptoms and acid suppression rather than a few years. I would rather treat the lifestyle drivers early in that person than manage the consequences later.
What the Research Shows
Yamasaki and colleagues used Explorys to track GERD incidence over an 11-year period. They looked at two levels: a “universal” dataset and a single healthcare system in northern Ohio, to see whether local trends matched the broader picture. Patients were sorted into seven age groups: 15 to 19, 20 to 29, 30 to 39, 40 to 49, 50 to 59, 60 to 69, and 70 and older.
The proportion of patients with GERD increased in every age group except those aged 70 and older in the universal dataset, and except those aged 60 and older in the healthcare system dataset (P < 0.001 for both). The steepest increase in both datasets was in the 30 to 39 age group (P < 0.001).
Proton pump inhibitor use followed the same shape. The proportion of GERD patients on a PPI increased in all age groups except those 70 and older in both datasets (P < 0.001), and again the largest increase was in the 30 to 39 group (P < 0.001).
Study Snapshot
This was a population-based analysis of the Explorys dataset covering an 11-year period, not a clinical trial and not a chart review of a single center. Incidence of GERD, along with several other variables, was evaluated across seven predefined age bands, and the universal dataset was compared against a northern Ohio healthcare system to check whether local trends reflected the broader ones.
For context on the older picture, the authors cite a separate analysis by Johnson and Fennerty of 11,945 patients with erosive esophagitis enrolled in five prospective randomized controlled trials. There, severe erosive esophagitis became more common with age: 12% of patients under 21 had it, compared with 37% of those over 70, with the odds of severe esophagitis rising by 1.17 (95% CI, 1.13 to 1.20) per decade of age (P < 0.001).
Why This Matters for Health and Performance
GERD is common and getting more common. A recent systematic review cited by the authors put prevalence at 18.1% to 27.8% in North America, 8.8% to 25.9% in Europe, 2.5% to 7.8% in East Asia, 8.7% to 33.1% in the Middle East, 11.6% in Australia, and 23.0% in South America. Reflux affects quality of life and creates real burden on the healthcare system.
The age story used to run one direction. Aging has been consistently associated with higher risk of GERD symptoms, and a meta-analysis found symptom prevalence higher in people aged 50 and over (OR, 1.32; 95% CI, 1.12 to 1.54). Aging was also linked to more hospitalizations for erosive esophagitis and GERD complications. Yet in the late 1980s the relationship ran the other way, with advancing age inversely correlated with hospitalization for esophagitis (OR for over 85 years, using 65 to 69 as the reference, 0.66; 95% CI, 0.65 to 0.67). The authors read that reversal as a cohort effect, meaning something about when you were born, not just how old you are, shapes your reflux risk.
If younger cohorts are now carrying the risk factors, the burden shifts earlier in life. That is the practical concern behind these numbers, and it is why a rise concentrated in the 30s deserves attention rather than reassurance.
Safety, Limits, and Caveats
Rising proportions can reflect changes in how readily GERD is diagnosed, not only changes in who actually has the disease. An observational dataset like this can show the trend but cannot establish what caused it.
The comparison was between a universal dataset and one healthcare system in northern Ohio, so the geographic anchor for the local half of the analysis is narrow. The meta-analysis the authors cite for the age and symptom association carried substantial heterogeneity between studies (I² = 91.5%, P < 0.001), which is worth keeping in mind when interpreting the older literature on age and reflux.
Practical Takeaways
- Do not dismiss persistent reflux symptoms in a 30-something as too young to be GERD. That is the age band where the increase was steepest.
- The risk factors the authors list are largely modifiable: high body mass index, limited physical activity, smoking, and the food and drink you consume.
- PPI use is climbing fastest in the same 30 to 39 group. Starting acid suppression in your 30s means a long runway, so it is worth pairing with a plan to address the drivers.
- Age is still a risk factor for severe erosive disease, so older patients with reflux symptoms warrant a lower threshold for evaluation.
- A diagnosis trend is not a diagnosis. Symptoms that persist deserve assessment by your own clinician rather than self-management from a prevalence statistic.
Related Studies and Research
- Global Prevalence and Risk Factors of Gastroesophageal Reflux Disease
- The Effects of Modifying Amount and Type of Dietary Carbohydrate on Esophageal Acid Exposure
- Physiology, Pepsin
- Fundic Gland Polyps: Should My Patient Stop Taking PPIs?
- Episode 25: The Great GERD Mistake - How Medicine Made Heartburn Worse and How to Fix It
FAQs
Which age group showed the biggest increase?
The 30 to 39 age group, in both the universal dataset and the northern Ohio healthcare system (P < 0.001 in each).
Did every age group show an increase?
Nearly. The proportion of GERD patients rose in all age groups except those aged 70 and older in the universal dataset, and except those aged 60 and older in the healthcare system.
Did proton pump inhibitor use follow the same pattern?
Yes. PPI use among GERD patients increased in all age groups except those 70 and older in both datasets, with the largest increase again in the 30 to 39 group.
What risk factors do the authors link to rising GERD prevalence?
Older age, male sex, race, intake of analgesics, consumption of certain foods and drinks, declining Helicobacter pylori prevalence, smoking, family history of GERD, high body mass index, and limited physical activity. The authors note these are mostly lifestyle-related.
Does being younger mean milder disease?
Not necessarily milder, but severe erosive esophagitis does track with age. In the separate trial dataset the authors cite, 12% of patients under 21 had severe erosive esophagitis compared with 37% of those over 70.
Bottom Line
Over an 11-year period, the proportion of patients carrying a GERD diagnosis rose across almost all age groups, and rose most sharply in people aged 30 to 39. Prescriptions for acid suppression moved the same way in the same group. Reflux is no longer something to file under middle age, and the earlier the lifestyle drivers get addressed, the shorter the runway of symptoms and medication that follows.
